Drug recall · June 19, 2024
Phenazopyridine HCl recall
Why: Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA
- Lots / codes
Lot # B2906961-042524, exp. date 02/26/2027
- Quantity
- 8 bottles
- Company
- RemedyRepack Inc., Indiana, PA
- Distribution
- Product was distributed to one medical facility.
- Initiated
- May 31, 2024 · Voluntary: Firm initiated
- Classified
- June 10, 2024
- Reported
- June 19, 2024
- Ended
- July 1, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenazopyridine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.